Maintenance of Therapeutic Plasma Aprotinin Levels During Prolonged Cardiopulmonary Bypass Using a Large-Dose Regimen

This publication has 12 references indexed in Scilit:

• Influence of High-dose Aprotinin on Anticoagulation, Heparin Requirement, and Celite- and Kaolin-Activated Clotting Time in Heparin-pretreated Patients Undergoing Open-Heart Surgery
  Anesthesiology, 1995
• Pharmacokinetics of Aprotinin in Preoperative Cardiac Surgical Patients
  Anesthesiology, 1994
• Perioperative approaches to coagulation defects
  The Annals of Thoracic Surgery, 1993
• Effect of Hypothermia and Sampling Site on Blood Esmolol Concentrations
  The Journal of Clinical Pharmacology, 1993
• High-dose aprotinin therapy: A review of the first five years' experience
  Journal of Cardiothoracic and Vascular Anesthesia, 1992
• Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial Revascularization
  Anesthesiology, 1990
• Augmentation of Kallikrein and Plasmin Inhibition Capacity by Aprotinin using a New Assay to Monitor Therapy
  Advances in experimental medicine and biology, 1989
• Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary Bypass
  The Annals of Thoracic Surgery, 1987
• Sufentanil disposition during cardiopulmonary bypass
  Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 1987
• Effect of Cardiopulmonary Bypass on the Pharmacokinetics of Drugs
  Clinical Pharmacokinetics, 1982